Axelyf was founded by Orn Almarsson in 2025.

Who are Axelyf's investors?

Axelyf's investors include Brunnur Ventures GP.

How much funding has Axelyf raised?

Axelyf has disclosed $4.8M raised across 1 round.

Where is Axelyf headquartered?

Axelyf is headquartered in Chestnut Hill, US.

Axelyf

Chestnut Hill, US · Founded 2025 · Delaware corporation · 14 employees on LinkedIn · 1 known investors

Find your way into Axelyf

734 people in our graph share verified history with the Axelyf team — schools, employers, funds. One of them is your warm intro.

Óskar Fannar Vilmundarsonunlockedknows Orn Almarsson · together at Axelyf (overlapped)

×6knows the team · via Moderna

×5knows the team · via J&J PRD

Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences. The company focuses on RNA therapeutics platform development and associated therapeutic programs.

AI & Machine Learning Biotech Deep Tech Healthtech

Founders & leadership

Axelyf was founded in 2025 by Orn Almarsson.

Orn Almarsson Co-FounderOrn Almarsson is leading Axelyf, an RNA medicine company developing therapies for autoimmune disease and oncology using lipid nanoparticle technology. He previously served as head of delivery science and process chemistry at Moderna, where he contributed to lipid nanoparticle development, and earlier held roles at Merck in the mid-1990s.

Board

Arni Blondal Board MemberFounding Partner at Brunnur Ventures GP

John LucasBoard director

Investors · 1

Brunnur Ventures GP✓ confirmed by AxelyfReykjavik · $1M – $3M

How we know: Brunnur Ventures GP's portfolio page · the company's own site · funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$4.8M disclosed across 1 round · 2025

▶$4.8MraisedAug 2025 · 37 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

John LucasDirector
Arni BlondalDirector
Orn AlmarssonExecutive Officer, Director, Promoter

Offering amount: $6.3M
Amount sold: $4.8M
First sale: Jul 2025
Incorporated: Corporation, Delaware, 2025
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Axelyf Closes $2.6M Seed Financingfinsmes.com · Aug 2025

Frequently asked questions

What does Axelyf do?: Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences. The company focuses on RNA therapeutics platform development and associated therapeutic programs.
Who founded Axelyf?: Axelyf was founded by Orn Almarsson in 2025.
Who are Axelyf's investors?: Axelyf's investors include Brunnur Ventures GP.
How much funding has Axelyf raised?: Axelyf has disclosed $4.8M raised across 1 round.
Where is Axelyf headquartered?: Axelyf is headquartered in Chestnut Hill, US.